CRC clinical investigators are participating in the listed clinical trials. Site participation varies. In order to find out more about the clinical trials occurring at the CRC site nearest you, please click on CRC Sites. The research nurses/coordinators will be able to assist you with the details of these clinical trials and others being conducted at each local site. What is a Clinical Trial?

Active Accrual

CRC000: CLL Research Consortium Tissue Core Sample Collection Study and Familial

Non Intervention Protocols

CRC043: Venetoclax + Rituximab + EPOCH for Patients with Richters Transformation

Non Intervention Protocols

CRC044: Early Treatment with Ibrutinib for Patients with High-Risk CLL

Non Intervention Protocols

CRC046: Ibrutinib + Venetoclax for Patients with High-Risk Treatment Naïve CLL, or Relapsed/Refractory CLL

Non Intervention Protocols

CRC047: Anti-PDL-1 mAb + Obinutuzumab + Ibrutinib for Relapsed/Refractory CLL

Non Intervention Protocols

CRC048: Nivolumab + Ibrutinib for Richters Transformation

Non Intervention Protocols

CRC049: Cirmtuzumab + Ibrutinib for Patients with Relapsed/Refractory CLL

Non Intervention Protocols